Dr. Mark Kester

G. Thomas Passanati Distinguished professor of Pharmacology, and the former Pharmacology Department Head at Penn State University College of Medicine. A leader in NanoMedicine at Penn State, he is a serial health care entrepreneur with notable technology commercialization successes in the fields of improved stents, nanoliposome’s, and the therapeutic applications of Ceramide for cancer treatment.

James H. Adair

Director of the Ceramic & Composite Materials Center and a Professor in Materials Science and Engineering. His research and teaching interests include biologicalnanoscale particulates and phenomena, colloid and interfacial chemistry, material chemistry, particle characterization, and ceramic and metal powder State University of New York at Suny Brook

Jeff Davidson

Jeff is the CEO of Keystone Nano developers of the nanotechnology solutions for pharmaceutical and industrial applications. Mr. Davidson has a BS in Chemical Engineering from Purdue University and an MBA from the University of Minnesota and has 22 years of experience in industry and academia. He served as the Executive Director of the Bioprocessing Resource Center, the founder and Executive Director of the Pennsylvania Biotechnology Association for 9 years, the founder and publisher of Your World a magazine of biotechnology applications for 12 years, the founder of the Biotechnology Institute (a national biotechnology education nonprofit), as the founder of BioSciEd, Inc. and is currently managing the delivery of business growth services for the IMC.

Paul Gray

Paul is an active early stage investor and strategic consultant to numerous development stage companies.   He is an audit committee financial expert as defined under the rules and regulations of the Securities and Exchange Commission and meets the financial sophistication requirements of the listing standards of the NASDAQ.
He currently is the Managing Member of Core Concepts, LLC, a strategic and financial consulting firm which he founded in 2002. Mr. Gray has been a member of the Board of Directors of United Therapeutics Corporation since 2003 and currently serves as Chairman of their audit committee and member of the compensation committee.  He also is Chairman of the Board of several companies in which he has invested including Red Branch Technologies, Inc., a comprehensive online travel company, Critical Solutions, Inc., the provider of alternative energy power platforms and Nano Therapies, LLC, a company specializing in drug delivery utilizing unique nano particles.  From 1985 to 1999, Paul practiced as a Certified Public Accountant at Ernst & Young LLP, KPMG LLP and Beers & Cutler LLP.  He has served as an Officer and/or Chief Financial Officer for his client’s and portfolio companies from time to time.
Paul has a passion for the advancement and development of life-changing and paradigm shifting technologies and has actively invested his time and money to this pursuit and related opportunities.

Doug Foran

Doug specializes in taking new companies and new technologies to market. He was an early contributor to the Silicon Valley leader for integrated circuit design, Calma Corporation. He pioneered the Electronic Technical Publishing market at Information Displays Inc., which dominated this market niche and attained NASDAQ National Market status. At Xerox Corporation he started up two business teams solving problems in asset management for utility companies and technical document management for manufacturing companies, world-wide. He launched Concept Five Technologies as an early entrant in cyber security for pharmaceutical and financial services markets.
Today, Doug provides leadership and strategic guidance for commercialization and branding as part of a small team of entrepreneurs launching companies focused on energy, security and bio-tech solutions. He has taken a leadership role at NanoTherapies to drive the early-stage commercialization of nanotechnology innovations for treatment of cancer.